reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
6 recorded connections shown. Select a record, office or person to follow its source references.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
The source record
The source did not record a date for this entry.
- Jurisdiction code
- SD
- Identifier
- HB 1099
- Number
- 1099
- Title
- reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
- Is law candidate
- true
- Current stage
- enacted
- Latest action at
- 2026-03-10T00:00:00+00:00
- Official url
- https://openstates.org/
- Source updated at
- 2026-04-24T07:08:35.225534+00:00
- First seen at
- 2026-09-02T01:24:59.975654+00:00
- Last seen at
- 2026-10-05T09:01:12.958048+00:00
- Metadata
- {}
- Government level
- state
Every link on this map
The same connections as a table, with the reason each one is here.
| Measures | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to Measures. | None |
| HB 1099: reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to HB 1099. | None |
| South Dakota 2026 | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to South Dakota 2026. | None |
| South Dakota | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to South Dakota. | None |
| ocd-bill/0e6db9e8-e382-4100-b698-bf00e9cd3edf | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to ocd-bill/0e6db9e8-e382-4100-b698-bf00e9cd3edf. | None |
| South Dakota | What this connects to | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. has a recorded connection to South Dakota. | None |